News

Urgent Call for Research on Pancreatic Cancer Survival Rates

Urgent Call for Research on Pancreatic Cancer Survival Rates

Pancreatic Cancer Survival Rates Remain Stagnant

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients

Recent statistics reveal that the five-year relative survival rate for pancreatic cancer stands at a disheartening 13%. This figure has not improved over the past few years despite significant increases in diagnoses. For pancreatic adenocarcinoma, the most prevalent type of pancreatic cancer, the survival rate drops even further to just 8%. Even as advancements are made in cancer treatments overall, pancreatic cancer remains a formidable enemy, currently ranking as the third-leading cause of cancer-related deaths in the United States. Alarmingly, experts warn that it may soon ascend to the second spot.

The Growing Challenge of Pancreatic Cancer

This year alone, around 67,440 individuals are expected to receive a pancreatic cancer diagnosis, with an estimated 51,980 succumbing to the disease. The survival rate for Black individuals diagnosed with pancreatic cancer is even more troubling, sitting at a mere 11%. These disparities underline the urgent need for improved detection and treatment options.

Current Obstacles in Treatment

Dr. Anna Berkenblit, Chief Scientific and Medical Officer at PanCAN, highlights a troubling reality - despite incremental progress in pancreatic cancer treatments, survival rates have stagnated. The continued prevalence of pancreatic cancer as a leading cause of cancer death is a wake-up call for the medical community. The lack of a standardized screening process for pancreatic cancer, unlike for other major cancers such as lung or breast cancer, compounds the challenge. Better screening tools and therapies are essential to bridge the gap in outcomes.

New Strategies for Early Detection

In an effort to revitalize the fight against pancreatic cancer, PanCAN has initiated innovative research aimed at early detection strategies. By investigating the correlation between high blood sugar levels and pancreatic cancer, researchers hope to develop a screening method that identifies the disease at a stage when treatment is most effective.

The Push for Personalized Treatments

The development of tailored treatment options has gained momentum, with four new drugs being approved for pancreatic cancer in a single year. This progress not only highlights the advancements in precision medicine but also illustrates the necessity of ongoing research funding to continue the innovative efforts needed for better outcomes.

Community Support for Patients and Families

PanCAN has emerged as a leading organization capable of supporting pancreatic cancer patients and their families. They provide a wealth of educational resources and professional support services at no charge, making them a crucial ally for those impacted by the disease. Through their comprehensive approach, PanCAN aims to empower patients by equipping them with the knowledge they need to advocate for their healthcare needs.

About PanCAN's Mission and Goals

Through its rigorous advocacy and research initiatives, PanCAN aspires to lift the five-year survival rate for pancreatic cancer to 20% by the end of the decade. For over two decades, PanCAN has driven significant strides in the quest for effective treatments and early detection methods, rallying a community dedicated to making a lasting impact in the realm of pancreatic cancer.

Frequently Asked Questions

What are the current survival rates for pancreatic cancer?

The five-year relative survival rate for pancreatic cancer is currently 13%, while for pancreatic adenocarcinoma, it is as low as 8%.

Why is pancreatic cancer particularly challenging to treat?

Pancreatic cancer is difficult to treat due to its aggressive nature and the lack of early detection strategies, which means many patients are diagnosed at more advanced stages.

What is PanCAN doing to address pancreatic cancer?

PanCAN is actively conducting research initiatives focused on early detection, personalized treatments, and providing support for patients and their families.

How can individuals support the mission against pancreatic cancer?

Individuals can contribute by raising awareness, supporting research funding, and participating in events organized by PanCAN to benefit the community.

What resources does PanCAN offer for patients?

PanCAN offers a variety of resources, including educational materials and professional support, all available free of charge to individuals affected by pancreatic cancer.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Waters Acquires MOBILion: Ion Mobility Meets AI

Updated Category News Views 12

MOBILion Joins Waters' Fold: A New Era for Proteomics Ah, the biotech world just saw another big whirl with Waters Corporation snagging MOBILion Systems. Now, this isn't just some stroll in the market park. We're talking about weaving MOBILion's fancy high-resolution ion mobility separation tech right into Waters' already robust mass spectrometry setup. These folks are...

Continue Reading
Sandals & Beaches Black Friday: Up to 65% Savings

Updated Category News Views 0

Vacation Savings So Sweet They’re Hard to Ignore If you’ve been dreaming of a sun-soaked escape, Sandals and Beaches Resorts have rolled out deals so compelling, they’re practically begging you to pack your bags. This year, from November 3 until December 1, travelers can dive into savings of up to 65% combined with air credits reaching up to $750. In a move clearly...

Continue Reading
Cambiotics Launches Key Trial on Reducing PFAS in Firefighters

Updated Category News Views 0

Pioneering Efforts to Combat 'Forever Chemicals' Cambiotics is stepping into some uncharted territory—tackling the tricky problem of PFAS accumulation in firefighters. If you’ve been following this, PFAS, or per- and polyfluoroalkyl substances, have been living rent-free in our bodies for years. Used in firefighting equipment and foams, these chemicals stick around,...

Continue Reading
MemorialCare Expands Cutting-Edge GERD Treatment Options

Updated Category News Views 168

Shifting the GERD Treatment Paradigm While everyone's talking about breakthrough technologies like AI and blockchain in medicine, MemorialCare seems to have quietly flipped the script on treating gastroesophageal reflux disease (GERD). They're sidestepping conventional maneuvers by embracing two procedures known as transoral incisionless fundoplication (TIF) and its...

Continue Reading
Staypineapple Backs Vets: A Heartwarming Initiative

Updated Category News Views 0

When Hotels Stand Up for Heroes Every now and then, you stumble upon a company doing something genuinely good, and Staypineapple's effort this November is one of those rare gems. In honor of Veterans Day, they're opening their checkbook to sling some real support to our nation’s vets and retired first responders. Their chosen cause? The American Humane Society's...

Continue Reading
Danaher CEO Takes Center Stage at Healthcare Conferences

Updated Category News Views 35

Danaher in the Healthcare Spotlight Phew, here we go—Danaher's big shot, President and CEO Julie Sawyer Montgomery, is gearing up to turn heads at not one, but two major healthcare conferences. First stop: the UBS Global Healthcare Conference in sunny Palm Beach, Florida on November 9th, bright and early. Then she'll be hopping across the pond to chime in at the...

Continue Reading
Ally Financial Scores High Marks: Banking and Workplace

Updated Category News Views 185

Ally's Impressive Award Sweep Takes the Spotlight There's something palpable about consistently being on top of the game in a sector as cutthroat as banking. Ally Financial is turning heads with a series of recognitions that paint a picture of a company doing more than just crunching numbers under the ticker NYSE:ALLY. Why Ally Bank Tops the Banking Charts Ally's been...

Continue Reading
Oracle's $20 Billion Offering: What Investors Need to Know

Updated Category News Views 97

Oracle's Big Play: A $20 Billion Offering Nobody said playing in the big leagues was easy, and Oracle seems to be doubling down on that idea. Today, they spilled the beans on their ambition to rake in a cool $20 billion through an offering of common stock and senior notes. For those of us who keep a close eye on NYSE:ORCL, this is more than just a number—it's a signal...

Continue Reading
Syra Health Hits Record Revenue, Sustains Growth

Updated Category News Views 45

Syra Health Reports Stellar Q3 Performance Folks, let's dive right into the figures: Syra Health's Q3 2026 performance is nothing short of a powerhouse display. We're talking about a jaw-dropping 52% surge in revenue compared to the same period last year, climbing to a record $2.6 million. It's not often you see a company swing its EPS from a loss of $(0.02) to a positive...

Continue Reading
Metals Producers Rise Despite Futures Dip: Election Day Buzz

Updated Category News Views 0

Election Day Drama: Metals Market Jitters You'd think with all the election day hoopla, the metal futures would hold steady. But here we are, seeing gold, silver, and copper futures retracting like a scared turtle. Monday, they all roared upward. Tuesday morning, they're backpedaling. December gold futures took a hit, dropping 0.78% to land at $3,938.50 an ounce. Silver...

Continue Reading

Top 5 Most Recently Viewed Articles

Zillow Group to Showcase Innovations at Leading Tech Conference

Updated Category News Views 153

Zillow Group’s Participation at Barclays Technology Conference Zillow Group, Inc. (NASDAQ: Z) is making waves in the real estate market by transforming how individuals buy, sell, rent, and finance homes. Recently, Zillow Group announced it will present at the Barclays 23rd Annual Global Technology Conference. This prestigious event serves as a platform for innovative...

Continue Reading
Albion Technology & General VCT PLC Announces New Equity Issue

Updated Category News Views 120

Albion Technology & General VCT PLC Introduces New Equity Albion Technology & General VCT PLC, often recognized for its strategic investments, has made a significant announcement regarding the issuance of new shares. This move is part of their ongoing commitment to enhancing shareholder value through initiatives like the Dividend Reinvestment Scheme. Details of the Share...

Continue Reading
Regency Centers Achieves 'A-' Credit Rating from S&P Global

Updated Category News Views 114

Regency Centers Receives Upgrade in Credit Rating Regency Centers Corporation recently announced an important milestone in its journey towards exceptional financial strength. The company, well-known in the retail sector, has received an upgrade to an ‘A-’ credit rating from S&P Global Ratings. This recognition signals a positive outlook for Regency and underscores its...

Continue Reading
Transformative Financing for Mirxes to Enhance Cancer Detection

Updated Category News Views 110

R-Bridge Financing: A Major Step for Cancer Diagnostics R-Bridge has made waves in the healthcare sector by offering bespoke financing of US$40 million structured as a synthetic royalty. This unique financial arrangement is designed to support the innovative efforts of Mirxes, a company specializing in early detection solutions for cancer through cutting-edge miRNA...

Continue Reading
Leadership Transition at M.D.C. Holdings: A New Chapter Begins

Updated Category News Views 184

Executive Leadership Changes at M.D.C. Holdings M.D.C. Holdings, Inc. has made headlines recently with the announcement that its Founder and Executive Chairman, Larry A. Mizel, along with President and CEO David D. Mandarich, will be stepping down from their roles. This decision marks the end of an era for one of the leading homebuilders in the United States, with a...

Continue Reading